Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer	Advanced HR+/HER2- Breast Cancer	Recruiting	Phase 1	2026-10-09		NCT07604571

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Novartis Pharmaceuticals	432

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
Mary Crowley Cancer Research	Dallas	United States	5
Univ of Kansas Hosp and Med Ctr	Kansas City	United States	2
Yale New Haven Hospital	New Haven	United States	27

Clinical trials